tirzepatide drug company FDA Grants a New Indication for Obesity Management Lilly's Weight-Loss Drug Approved in

Listen to the full episode for Sophie's five quick wins and Marolijn's pratcical tips on where to find trustworthy nutrition information

But notice the initiation dose of 0.25 mg converts to only 2.5 units

20 September 2017

In June 2021, the FDA approved Semaglutide (Wegovy), a GLP-1 receptor agonist developed by Novo Nordisk, for use as a weight loss drug

Rama Rao KV, Jayakumar AR, Tong X, Curtis KM, Norenberg MD (2010) Brain aquaporin-4 in experimental acute liver failure

Yet, in the process of transporting free fatty acids from the cytosol (insides) of a cell to the mitochondria where fatty acids are burned to generate energy (ATP) and heat, there is one key molecule L-carnitine